AIDS Research Alliance of America (ARAA) was a national community-based 501(c)(3) non-profit medical research institution that sought to develop a cure for HIV/AIDS, medical strategies to prevent new HIV infections and better treatments for people living with HIV/AIDS.[1] From 1989 to 2015, ARAA conducted over 150 clinical and pre-clinical studies,[2] ranging from alternative therapies[3][4][5] that employed a complementary approach to HIV care to the first in-human HIV vaccine trial.[6] AIDS Research Alliance was partly responsible for "fast-tracking" to market half of today's anti-HIV treatments.